ARCHIVE

• Korosho to Require Nationwide Supply of Generics with a Full Range of Specifications
  November 28, 2005

• Generics' Brand Names Are Confusing: Prof. Sato of Chuo Univ.
  November 28, 2005

• BUSINESS NEWS IN BRIEF
  November 28, 2005

• Artz to Grow Despite Severer Competition: Mr Mizutani of Seikagaku Corp.
  November 28, 2005

• 1st 3 QTRS BUSINESS RESULTS
  November 28, 2005

• SEMIANNUAL BUSINESS RESULTS -2-
  November 28, 2005

• Equal Partnership Needed between Investigators, Monitors and the CRC: JCROA Symposium
  November 28, 2005

• SEMIANNUAL BUSINESS RESULTS
  November 28, 2005

• SEMINAR
  November 28, 2005

• Importance of Overseas Business Increases for Major Domestic Companies
  November 28, 2005

• SURVEY 2 articles
  November 28, 2005

• 13 Leading Pharma Companies Report 3.5% Growth in Sales: JPMA
  November 28, 2005

• Drug Benefits Discussed by EAD Director Futagawa
  November 21, 2005

• JMA Objects that GPs Income Is Not as High as Reported by Korosho
  November 21, 2005

• Medical Fees Must Be Reduced by at Least 3%: MOF Council
  November 21, 2005

• FPMAJ's Mr Mukaida Criticizes Korosho's Reform Proposals
  November 21, 2005

• MOF Proposes to Exclude "Non-prescription Drugs" from Insurance Coverage: Mr Mugitani
  November 21, 2005

• BUSINESS NEWS IN BRIEF
  November 21, 2005

• IMS Health Predicts 6-7% Growth in Global Drug Market in 2006
  November 21, 2005

• Worldwide Sales of Olmesartan to Top \100 Bil. in 2006: Daiichi Sankyo
  November 21, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 435
• 436
• 437
• 438
• 439
• 440
• 441
• 442
• 443
• …
• Next ›
• 最終 »